MedTrace Logo

CoVid-19 - Infection and Antibody Formation in the Viennese Population

NCT04346264 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12419

Last updated 2022-05-04

No results posted yet for this study

Summary

Summary of the study

Study population:

A representative sample of the Viennese population stratified by age and gender (data from the Vienna Health Study LEAD)

Potential output and analysis:

* Extent of age-specific infection and antibody formation
* Cumulative incidence of infection
* Rate of asymptomatic infection
* Relationship with socioeconomics, lifestyle and risk factors (comorbidities)

Study design:

Prospective, longitudinal, stratified by age and gender

Duration of study:

Initial testing as soon as possible and repeat based on monitoring of the pandemic curve (probably after 2-3 months)

Information to be obtained from participants:

* serum samples for information on SARS-CoV2 infection and antibody formation
* data on clinical symptoms

Conditions

Interventions

DIAGNOSTIC_TEST

NO intervention planned due to the observational study design only a diagnostic testing

Only a diagnostic test (serum blood and antibody measurement) is planned

Sponsors & Collaborators

  • Ludwig Boltzmann Institute for Lung Health

    lead OTHER

Principal Investigators

  • Otto C Burghuber, Prof.MD · Ludwig Boltzmann Institute for Lung Health

Eligibility

Min Age
6 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-27
Primary Completion
2020-05-27
Completion
2020-05-27

Countries

  • Austria

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04346264 on ClinicalTrials.gov